Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Ephedrine recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Ephedrine (44 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Ephedrine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Ephedrine recalls on record

none so far in 2026; 44 on record, newest first
Class II · Moderate risk

Ephedrine Sulfate Injection

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.

Terminated Sterility / contamination Sandoz Inc NDC 66758-008-01 D-1513-2016
Class II · Moderate risk

Ephedrine Sulfate Injection

Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.

Terminated Sterility / contamination Allergy Laboratories, Inc. NDC 69053-008-02 D-1498-2016
Class II · Moderate risk

ePHEDrine Sulfate PF

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3084-07 D-0251-2016
Class II · Moderate risk

ePHEDrine Sulfate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0031-2017
Class II · Moderate risk

ePHEDrine Sulfate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0030-2017
Class II · Moderate risk

ePHEDrine Sulfate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0029-2017
Class II · Moderate risk

ePHEDrine Sulfate Injection

Labeling: Label Error on Declared Strength; The outer light protective bags, where the ephedrine sulfate injection syringes are stored, were mislabeled with 25 mg/mL in big font and 5 mg/mL in small font, however, the actual syringes were correctly labeled as 25 mg/5 mL.

Terminated Labeling / mix-up US Compounding Inc D-1548-2014
Class III · Low risk

Bronkaid Dual Action Formula

Labeling: Label lacks warning or Rx legend; Certain information was inadvertently excluded from the product carton label.

Terminated Labeling / mix-up Bayer Healthcare, LLC D-177-2013